Exact Mass: 841.3521

Exact Mass Matches: 841.3521

Found 15 metabolites which its exact mass value is equals to given mass value 841.3521, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

CDP-DG 24:0

1,2-Didodecanoyl-sn-glycero-3-cytidine-5-diphosphate

C36H65N3O15P2 (841.3891)

CDP-DG(i-12:0/i-12:0)

({[(2R)-2,3-bis[(10-methylundecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)({[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinate

C36H65N3O15P2 (841.3891)

CDP-DG(i-12:0/i-12:0) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(i-12:0/i-12:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05\\% or so of the total phospholipids).

Senktide

3-[(3-Carboxy-1-hydroxypropylidene)amino]-3-[(1-{[1-({[(1-{[1-(C-hydroxycarbonimidoyl)-3-(methylsulphanyl)propyl]-C-hydroxycarbonimidoyl}-3-methylbutyl)-C-hydroxycarbonimidoyl]methyl}-C-hydroxycarbonimidoyl)-2-phenylethyl](methyl)carbamoyl}-2-phenylethyl)-C-hydroxycarbonimidoyl]propanoic acid

C40H55N7O11S (841.368)

Sulfurmycin F

C43H55NO16 (841.3521)

3-[O-alpha-L-arabinofuranosyl-(1?3)-beta-D-fucopyranosyl-(1?3)-beta-D-fucopyranosyl-(1?4)-{beta-D-quinovopyranosyl-(1?2)}-beta-D-quinovopyranosyl]-2-acetyl-pyrrole|astebatherioside A

C35H55NO22 (841.3216)

2-O-Methy-rG(N-Ac)Phosphoramidite

C43H52N7O9P (841.3564)

EPITAXOL C, 7-(P)

C46H51NO14 (841.3309)

Succinyl-(Asp6,N-Me-Phe8)-Substance P (6-11)

N-(1-{[1-({[1-(1-Carbamoyl-3-methylsulfanyl-propylcarbamoyl)-3-methyl-butylcarbamoyl]-methyl}-carbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl}-2-phenyl-ethyl)-3-(3-carboxy-propionylamino)-succinamic acid

C40H55N7O11S (841.368)

Senktide is a tachykinin NK3 receptor agonist.

1,2-Didodecanoyl-sn-glycero-3-cytidine 5-diphosphate

C36H65N3O15P2 (841.3891)

A CDP-diacylglycerol in which the acyl groups at positions 1 and 2 are specified as dodecanoyl.

depalmitoyl-aculeacin A

C35H53N8O16+ (841.3579)

CDP-DG 12:0/12:0

C36H65N3O15P2 (841.3891)

methyl (1s,2r,4r)-4-{[(2s,4s,5s,6s)-4-(dimethylamino)-5-{[(2r,4s,5s,6s)-4-hydroxy-5-{[(2s,5s,6r)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1s,2r,4r)-4-{[(2s,4s,5s,6s)-4-(dimethylamino)-5-{[(2r,4s,5s,6s)-4-hydroxy-5-{[(2s,5s,6r)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

C43H55NO16 (841.3521)

methyl (1r,2s,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5r,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2s,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5r,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

C43H55NO16 (841.3521)

methyl (1r,2s,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2s,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

C43H55NO16 (841.3521)

methyl (1s,2r,4s)-4-{[(2s,4s,5r,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5r,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1s,2r,4s)-4-{[(2s,4s,5r,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5r,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

C43H55NO16 (841.3521)